|
Leap Therapeutics inc (NASDAQ: LPTX) |
|
Leap Therapeutics inc
LPTX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Leap Therapeutics Inc 's sales fell
in IV. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.85 %
Leap Therapeutics Inc net loss increased from $-12 millions, to $-15 millions in IV. Quarter 2024,
• More on LPTX's Growth
|
|
Leap Therapeutics Inc realized a net loss in trailing twelve months.
Leap Therapeutics Inc realized cash reduction of $ -0.63 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.
• More on LPTX's Valuation
|
|
|
|
|
Leap Therapeutics Inc realized net loss in trailing twelve months.
Leap Therapeutics Inc realized cash outflow of $ -0.63per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.
Leap Therapeutics Inc Price to Book Ratio is at 0.4 lower than Industry Avg. of 77.28. and higher than S&P 500 Avg. of 0.01
• More on LPTX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com